Reedy E A, Heatfield B M, Trump B F, Resau J H
Department of Pathology, University of Maryland School of Medicine, Baltimore.
Pathobiology. 1990;58(1):15-27. doi: 10.1159/000163561.
The discrimination of atypical (premalignant) cells from invasive neoplastic cells in primary bladder lesions is a major diagnostic problem in cytopathology and surgical pathology. We have used an animal model of urinary bladder carcinogenesis to determine the specific changes which occur in the expression of certain cytokeratins (CK) during the progression of lesions from regenerative hyperplasia and carcinoma in situ to transitional cell carcinomas. At sequential time points following exposure of the rat bladder epithelium to N-methyl-N-nitrosourea in vivo, immunohistochemical staining of CKs was evaluated in ethanol-fixed samples from the induced urothelial lesions using commercially available anti-CK mouse monoclonal antibodies. Specific changes were found in the expression of CKs 13, 18, and 19 during the neoplastic progression of induced urothelial lesions in the rat. These changes included the reciprocal loss of expression of CK 19 and the reappearance of CK 18 as malignant tumors developed. Invasive cells also did not express CK 13. Our results, based on the rat model, are similar to those reported by others on CK expression in human bladder tumors. Because these changes in CK expression occurred at specific points in the progression of urothelial lesions, the antibodies utilized in this study may be helpful in predicting the invasive potential of cells present in cytopathological specimens and tissue biopsies from human urothelial lesions.
在原发性膀胱病变中,鉴别非典型(癌前)细胞与浸润性肿瘤细胞是细胞病理学和外科病理学中的一个主要诊断难题。我们利用膀胱癌发生的动物模型,来确定在病变从再生性增生、原位癌发展到移行细胞癌的过程中,某些细胞角蛋白(CK)表达所发生的特定变化。在大鼠膀胱上皮在体内暴露于N-甲基-N-亚硝基脲后的连续时间点,使用市售的抗CK小鼠单克隆抗体,对诱导性尿路上皮病变的乙醇固定样本中的CK进行免疫组织化学染色评估。在大鼠诱导性尿路上皮病变的肿瘤进展过程中,发现CK13、CK18和CK19的表达有特定变化。这些变化包括随着恶性肿瘤的发展,CK19表达的相互丧失和CK18的重新出现。浸润性细胞也不表达CK13。基于大鼠模型的我们的结果,与其他人报道的人类膀胱肿瘤中CK表达的结果相似。由于CK表达的这些变化发生在尿路上皮病变进展的特定阶段,本研究中使用的抗体可能有助于预测人类尿路上皮病变的细胞病理学标本和组织活检中存在的细胞的浸润潜能。